Literature DB >> 16144215

Impaired coronary collateral vessel development in patients with proliferative diabetic retinopathy.

Turgay Celik1, M Eyup Berdan, Atila Iyisoy, Hurkan Kursaklioglu, Hasan Turhan, Selim Kilic, Mustafa Gulec, Sami Ozturk, Ersoy Isik.   

Abstract

BACKGROUND: Diabetic patients have been reported to have impaired coronary collateral vessel growth, although they have excessive neovascularization in the retina. HYPOTHESIS: This study was designed to compare coronary collateral circulation (CCC) in patients with proliferative diabetic retinopathy (PDR) with that in patients without DR.
METHODS: Ninety diabetic patients with chronic total occlusion in at least one major epicardial coronary artery were enrolled in the study. Groups 1 and 2 consisted of 48 patients without DR and 42 patients with PDR, respectively. Coronary collateral circulation (CCC) was analyzed according to the Rentrop system. Each group was also divided into two subgroups according to poor and good CCC. Serum vascular endothelial growth factor (VEGF) levels were measured using the enzyme-linked immunosorbent assay (ELISA) kit.
RESULTS: The mean Rentrop collateral score was higher in Group 1 than in Group 2 (2.39 +/- 1.07 vs. 1.76 +/- 0.76, respectively, p < 0.001). When the two groups were compared with respect to poor and good CCC, poor CCC was higher in patients with PDR (64 vs. 36%, respectively, p = 0.01). Serum VEGF levels were higher in patients with PDR than in those without DR (219 +/- 99 vs. 139 +/- 98 pg/ml, p < 0.001); however, patients with poor and good CCC had similar VEGF levels.
CONCLUSIONS: We have shown that patients with PDR have a lower coronary collateral score than patients without DR. Also, serum VEGF was significantly higher in patients with PDR than in those without DR. These findings have suggested that diabetes mellitus may have a different action on retinal and coronary circulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16144215      PMCID: PMC6654549          DOI: 10.1002/clc.4960280808

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  22 in total

Review 1.  Mechanisms of angiogenesis and arteriogenesis.

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

Review 2.  Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease.

Authors:  N van Royen; J J Piek; I Buschmann; I Hoefer; M Voskuil; W Schaper
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

3.  Effect of diabetes mellitus on formation of coronary collateral vessels.

Authors:  A Abaci; A Oğuzhan; S Kahraman; N K Eryol; S Unal; H Arinç; A Ergin
Journal:  Circulation       Date:  1999-05-04       Impact factor: 29.690

Review 4.  Molecular mechanisms of blood vessel growth.

Authors:  E M Conway; D Collen; P Carmeliet
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

5.  Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue.

Authors:  Eva Chou; Izumi Suzuma; Kerrie J Way; Darren Opland; Allen C Clermont; Keiko Naruse; Kiyoshi Suzuma; Nancy L Bowling; Chris J Vlahos; Lloyd Paul Aiello; George L King
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

6.  Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways.

Authors:  C Miele; J J Rochford; N Filippa; S Giorgetti-Peraldi; E Van Obberghen
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

Review 7.  Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications.

Authors:  J Waltenberger
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

8.  Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation.

Authors:  A Schultz; L Lavie; I Hochberg; R Beyar; T Stone; K Skorecki; P Lavie; A Roguin; A P Levy
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

9.  Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals.

Authors:  J Waltenberger; J Lange; A Kranz
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

Review 10.  Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.

Authors:  E Duh; L P Aiello
Journal:  Diabetes       Date:  1999-10       Impact factor: 9.461

View more
  6 in total

Review 1.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 2.  Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.

Authors:  Eric J Belin de Chantemele; David W Stepp
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

3.  The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Maryam Akbari; Omid Reza Tamtaji; Kamran B Lankarani; Reza Tabrizi; Ehsan Dadgostar; Fariba Kolahdooz; Mehri Jamilian; Hamed Mirzaei; Zatollah Asemi
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-07-01

Review 4.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

5.  Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling.

Authors:  Roshini Prakash; Payaningal R Somanath; Azza B El-Remessy; Aisha Kelly-Cobbs; Javier E Stern; Paula Dore-Duffy; Maribeth Johnson; Susan C Fagan; Adviye Ergul
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

6.  Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia.

Authors:  Weiguo Li; Roshini Prakash; Aisha I Kelly-Cobbs; Safia Ogbi; Anna Kozak; Azza B El-Remessy; Derek A Schreihofer; Susan C Fagan; Adviye Ergul
Journal:  Diabetes       Date:  2009-10-06       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.